NL
The Yearly report is enclosed in this press release and is also available for download at the company’s web site, https://www.heliospectra.com/investor-relations/reports-presentations/
The year in brief
2019 was characterised by the decision taken in 2018 to renew the product portfolio with the development of MITRA. The decision involved a risk that sales would be affected, which was the case as sales fell by 43 per cent during the year. However, market acceptance of MITRA was good and we leave 2019 behind us with full orderbooks and a positive business momentum.